HomeCompareEDNSF vs PLD

EDNSF vs PLD: Dividend Comparison 2026

EDNSF yields 5714.29% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EDNSF wins by $228153224412503.13M in total portfolio value
10 years
EDNSF
EDNSF
● Live price
5714.29%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$228153224412509.59M
Annual income
$220,560,399,839,122,060,000.00
Full EDNSF calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — EDNSF vs PLD

📍 EDNSF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEDNSFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EDNSF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EDNSF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EDNSF
Annual income on $10K today (after 15% tax)
$485,714.29/yr
After 10yr DRIP, annual income (after tax)
$187,476,339,863,253,750,000.00/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, EDNSF beats the other by $187,476,339,863,249,300,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EDNSF + PLD for your $10,000?

EDNSF: 50%PLD: 50%
100% PLD50/50100% EDNSF
Portfolio after 10yr
$114076612206258.05M
Annual income
$110,280,199,919,563,650,000.00/yr
Blended yield
96.67%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

EDNSF
No analyst data
Altman Z
2.2
Piotroski
4/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EDNSF buys
0
PLD buys
0
No recent congressional trades found for EDNSF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEDNSFPLD
Forward yield5714.29%3.18%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$228153224412509.59M$6.50M
Annual income after 10y$220,560,399,839,122,060,000.00$5,256,436.18
Total dividends collected$227641622319776.13M$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: EDNSF vs PLD ($10,000, DRIP)

YearEDNSF PortfolioEDNSF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$582,129$571,428.57$11,255$555.24+$570.9KEDNSF
2$31,711,186$31,088,308.22$13,062$1,018.59+$31.70MEDNSF
3$1,616,661,128$1,582,730,159.44$15,903$1,926.67+$1616.65MEDNSF
4$77,139,944,357$75,410,116,950.20$20,839$3,823.32+$77139.92MEDNSF
5$3,445,379,409,484$3,362,839,669,021.90$30,464$8,166.08+$3445379.38MEDNSF
6$144,058,436,084,716$140,371,880,116,567.28$52,054$19,457.30+$144058436.03MEDNSF
7$5,639,412,164,337,400$5,485,269,637,726,755.00$109,886$54,188.93+$5639412164.23MEDNSF
8$206,716,597,857,094,600$200,682,426,841,253,570.00$304,030$186,451.18+$206716597856.79MEDNSF
9$7,096,097,732,137,874,000$6,874,910,972,430,782,000.00$1,166,125$840,813.32+$7096097732136.71MEDNSF
10$228,153,224,412,509,600,000$220,560,399,839,122,060,000.00$6,504,190$5,256,436.18+$228153224412503.13MEDNSF

EDNSF vs PLD: Complete Analysis 2026

EDNSFStock

Eden Research plc offers sustainable solutions for crop protection, animal health, and consumer products in the United Kingdom and rest of Europe. The company provides crop protection products for foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatment applications. It also offers animal health products, such as companion animal, bio-control, parasite treatments, and insect spray products. In addition, the company provides human health products comprising head-lice treatment products, fragrances, deodorants, wound-care products, food flavorings, odor neutralizers, and active ingredient supply/delivery products. The company was incorporated in 1995 and is headquartered in Abingdon, the United Kingdom.

Full EDNSF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this EDNSF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EDNSF vs SCHDEDNSF vs JEPIEDNSF vs OEDNSF vs KOEDNSF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.